What is Longeveron LLC (LGVN) stock price today?

Longeveron LLC (LGVN) currently trades at $0.85 per share. The stock has a market capitalization of $26.35M and a P/E ratio of —x.

Is LGVN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Longeveron LLC has a Smart Value Score of 15/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Longeveron LLC's revenue and earnings?

Longeveron LLC has trailing twelve-month (TTM) revenue of $1.20M with profit margins of 0.00%. Earnings per share (EPS) is $-1.29.

Is LGVN stock overvalued or undervalued?

Based on our DCF model, Longeveron LLC's intrinsic value is $1.32, representing a margin of safety of 59.00%. The stock currently trades at a P/E of —x.

LGVN

Longeveron LLC

NASDAQ: LGVN · HEALTHCARE · BIOTECHNOLOGY

$0.85

-1.74% today

Updated 2026-04-30

Market cap

$26.35M

P/E ratio

—

P/S ratio

21.98x

EPS (TTM)

$-1.29

Dividend yield

—

52W range

$0 – $2

Volume

6.9M

Market cap

$26.35M

P/E ratio

—

P/S ratio

21.98x

EPS (TTM)

$-1.29

Dividend yield

—

52W range

$0 – $2

Volume

6.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.5

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$5.48

+544.40%

12-Month target

—

Intrinsic (DCF)

$1.32

Margin of safety

+59.00%

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 59.00% below intrinsic value

Risks

- Thin margins at 0.00%

- Negative free cash flow $-5.48M

- Revenue declining -39.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.22M	$709000.00	$2.39M	$1.20M	$1.20M
Net income	$-18.84M	$-21.41M	$-15.97M	$-22.70M	$-5.44M
EPS	—	—	—	—	$-1.29
Free cash flow	$-14.82M	$-19.30M	$-14.86M	$-18.89M	$-5.48M
Profit margin	-1,541.33%	-3,020.17%	-667.77%	-1,893.58%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LGVN	$26.35M	15	2.7	2.5	6.7	5.0	+59.00%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Longeveron LLC trades at $0.85. Our Smart Value Score of 15/100 indicates the stock is weak. TTM revenue stands at $1.20M. Our DCF model estimates intrinsic value at $1.32.

Frequently asked questions

What is Longeveron LLC's stock price?

Longeveron LLC (LGVN) trades at $0.85.

Is Longeveron LLC overvalued?

Smart Value Score 15/100 (Grade F, Strong Sell). DCF value $1.32.

What is the price target of Longeveron LLC (LGVN)?

The analyst target price is $5.48, representing +544.4% upside from the current price of $0.85.

What is the intrinsic value of Longeveron LLC (LGVN)?

Based on our DCF model, intrinsic value is $1.32, a +59.0% margin of safety versus $0.85.

What is Longeveron LLC's revenue?

TTM revenue is $1.20M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio21.98x

ROE-164.70%

Beta-0.19

50D MA$0.86

200D MA$0.83

Shares out0.03B

Float0.02B

Short ratio—

Avg volume6.9M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LGVN vs LLY →LGVN vs JNJ →LGVN vs ABBV →Stock screener →